J.M. Verzijl

Adverse drug events in hospitalized patients

Patricia M. L. A. van den Bemt, Toine C. G. Egberts, A.W. Lenderink et al. · European Journal of Clinical Pharmacology · 1999 · 466 citations

Drug Hypersensitivity, Adverse Event, Patient Safety +6

Risk factors for the development of adverse drug events in hospitalized patients.

Patricia M. L. A. van den Bemt, Toine C. G. Egberts, A.W. Lenderink et al. · Pharmacy World & Science · 2000 · 100 citations

Drug Safety, Drug Hypersensitivity, Adverse Event +12

Incidence of Discontinuation of Highly Active Antiretroviral Combination Therapy (HAART) and Its Determinants

E.N. Van Roon, J.M. Verzijl, J.R. Juttmann et al. · Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology · 1999 · 88 citations

Decolonization of methicillin-resistant Staphylococcus aureus using oral vancomycin and topical mupirocin

B. Maraha, J. van Halteren, J.M. Verzijl et al. · Clinical Microbiology and Infection · 2002 · 34 citations · Full text

Methicillin-resistant Staphylococcus Aureus, Health Sciences, Antibiotics +11

Controlled release of morphine from a poloxamer 407 gel

Mark MPM Jansen, J.M. Verzijl, David M. Burger et al. · International Journal of Pharmaceutics · 2013 · 27 citations

Medicine, Poloxamer 407, Pharmacotherapy +4